Therapeutic End Points in Eosinophilic Esophagitis: Is Elimination of Esophageal Eosinophils Enough?

Clinical Gastroenterology and Hepatology

Volumn 10, Issue 7, 2012, Pages 750-752

  Hirano, Ikuo ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUTICASONE; PROTON PUMP INHIBITOR; STEROID;

DIET; DISEASE SEVERITY; DRUG FORMULATION; DRUG RESPONSE; DYSPHAGIA; EDITORIAL; EOSINOPHIL; EOSINOPHILIC ESOPHAGITIS; GASTROESOPHAGEAL REFLUX; HUMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

AEROSOLS; ANDROSTADIENES; ANTI-ALLERGIC AGENTS; EOSINOPHILIC ESOPHAGITIS; EOSINOPHILS; FEMALE; HUMANS; MALE;

EID: 84862664016     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2012.02.009     Document Type: Editorial

References (15)

1. Liacouras C.A., Furuta G.T., Hirano I., et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 2011, 128:3-20. quiz 21-22.
2. Straumann A., Conus S., Degen L., et al. Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol 2011, 9:400-409.
3. Kwiatek M.A., Hirano I., Kahrilas P.J., et al. Mechanical properties of the esophagus in eosinophilic esophagitis. Gastroenterology 2011, 140:82-90.
4. Roman S., Hirano I., Kwiatek M.A., et al. Manometric features of eosinophilic esophagitis in esophageal pressure topography. Neurogastroenterol Motil 2011, 23:208-214.
5. Alexander J.A., Jung K.W., Arora A.S., et al. Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol 2012, 10:742-749.
6. Furuta G.T., Liacouras C.A., Collins M.H., et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 2007, 133:1342-1363.
7. Spechler S.J., Genta R.M., Souza R.F. Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis. Am J Gastroenterol 2007, 102:1301-1306.
8. Molina-Infante J., Ferrando-Lamana L., Ripoll C., et al. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults. Clin Gastroenterol Hepatol 2011, 9:110-117.
9. Hirano I. Eosinophilic esophagitis and gastroesophageal reflux disease: there and back again. Clin Gastroenterol Hepatol 2011, 9:99-101.
10. Sridhara S., Ravi K., Smyrk T.C., et al. Increased numbers of eosinophils, rather than only etiology, predict histologic changes in patients with esophageal eosinophilia. Clin Gastroenterol Hepatol 2012, 10:735-741.
11. Teitelbaum J.E., Fox V.L., Twarog F.J., et al. Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate. Gastroenterology 2002, 122:1216-1225.
12. Remedios M., Campbell C., Jones D.M., et al. Eosinophilic esophagitis in adults: clinical, endoscopic, histologic findings, and response to treatment with fluticasone propionate. Gastrointest Endosc 2006, 63:3-12.
13. Lucendo A.J., Pascual-Turrión J.M., Navarro M., et al. Endoscopic, bioptic, and manometric findings in eosinophilic esophagitis before and after steroid therapy: a case series. Endoscopy 2007, 39:765-771.
14. Straumann A., Conus S., Degen L., et al. Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. Gastroenterology 2010, 139:1526-1537.
15. Aceves S.S., Newbury R.O., Chen D., et al. Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids. Allergy 2010, 65:109-116.